Clinical Trial Update: Conjugated Linoleic Acid (1:1 Isomer Mixture) Intake in Overweight People [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the intake of a 1:1 mixture of conjugated linoleic acid in overweight and obese adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Conjugated Linoleic Acid (CLA) 1:1 isomer mixture (conjugated linoleic acid)

Snippet

Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz | Conditions: Overweight, Obesity | Phase 4 | Status: COMPLETED